Clinical Trials
4 trialsNCT07493304 2026-05-29
ROXI-CAT-II
Regeneron Pharmaceuticals
Phase 3 Recruiting
NCT04618913 2026-05-26
VICTORIE
Pfizer
Active not recruiting
NCT05461807 2022-10-26
H2H-OSCAR-US
Bayer
Completed
NCT00320255 2016-08-16
A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer
Bristol-Myers Squibb
Phase 2 Completed